ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 329277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 329277; 2) Community: the network communities that were significantly associated with the response to NSC 329277; 3) Molecule: the relationships between components within communities and NSC 329277; 4) MDR: the compounds that were significantly associated with the NSC 329277.

NSC Compound Enrichment Correlation
NSC 736493 Indenoisoquinoline derivative 0.043472147060915 0.18408747
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.043472147060915 0.037321261
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.043472147060915 0.19447898
NSC 761980 Null 0.043472147060915 0.21361722
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0434721470609156 0.37273838
NSC 266491 Psorspermin 0.0434721470609156 0.17782737
NSC 294979 BLEOMYCIN-BAPP 0.0434721470609156 -0.061537924
NSC 312887 Fludarabine phosphate 0.0434721470609156 0.201605
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.0434721470609156 0.23384534
NSC 648148 Null 0.0434721470609156 0.20669042
Total:76  Current:72    [First] [Prev] [Next] [Last]